|
Re: 8 Minutes at AHA
|
10
|
Resverlogix Corp.
|
Oct 25, 2019 02:52PM
|
|
Re: Shake it Up!
|
10
|
Resverlogix Corp.
|
Dec 23, 2020 08:46AM
|
|
Re: Epigenetics
|
10
|
Resverlogix Corp.
|
Feb 13, 2022 05:48PM
|
|
Re: 0.05 P-values -- A bridge too far ?
|
10
|
Resverlogix Corp.
|
Feb 12, 2020 04:03PM
|
|
Re: Just back from IR,...
|
10
|
Resverlogix Corp.
|
Oct 27, 2019 10:24AM
|
|
Re: The problem...as I see it
|
10
|
Resverlogix Corp.
|
Oct 17, 2020 03:20PM
|
|
Re: SF
|
10
|
Resverlogix Corp.
|
Sep 16, 2020 06:32PM
|
|
Re: Biotech Valuation
|
10
|
Resverlogix Corp.
|
Mar 30, 2021 04:59PM
|
|
Re: December 22, 2020.
|
10
|
Resverlogix Corp.
|
Oct 09, 2020 06:14PM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
10
|
Resverlogix Corp.
|
Dec 22, 2020 04:02PM
|
|
Re: Shake it Up!
|
10
|
Resverlogix Corp.
|
Dec 23, 2020 07:14PM
|
|
Re: Take Home Points: not ready for use in patients
|
9
|
Resverlogix Corp.
|
Nov 16, 2019 05:11PM
|
|
Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
9
|
Resverlogix Corp.
|
Sep 18, 2020 04:12PM
|
|
Re: RVX gets Breakthrough Therapy Designation!!!
|
9
|
Resverlogix Corp.
|
Feb 03, 2020 04:34PM
|
|
Re: Trials and statistics, next steps
|
9
|
Resverlogix Corp.
|
Feb 11, 2020 04:50PM
|
|
Re: Jardiance info,...
|
9
|
Resverlogix Corp.
|
Dec 17, 2019 01:11PM
|
|
Long covid trials
|
9
|
Resverlogix Corp.
|
Jul 31, 2023 07:03PM
|
|
Re: Our own BKC on the webcast
|
9
|
Resverlogix Corp.
|
Feb 13, 2021 04:33PM
|
|
Re: December 22, 2020.
|
9
|
Resverlogix Corp.
|
Oct 08, 2020 05:06PM
|
|
Re: Potential market
|
9
|
Resverlogix Corp.
|
Nov 17, 2019 05:28PM
|
